HCV reinfection incidence among individuals treated for recent infection-Reference-Cited by-同舟云学术

HCV reinfection incidence among individuals treated for recent infection

Author:

Martinello M.¹,Grebely J.¹,Petoumenos K.¹,Gane E.²,Hellard M.³⁴⁵,Shaw D.⁶,Sasadeusz J.⁷,Applegate T. L.¹,Dore G. J.¹⁸,Matthews G. V.¹⁸

Affiliation:

1. Viral Hepatitis Clinical Research Program; Kirby Institute; UNSW Australia; Sydney NSW Australia

2. Auckland Hospital; Auckland New Zealand

3. Centre for Population Health; Burnet Institute; Melbourne Vic. Australia

4. Infectious Diseases Unit; Alfred Hospital; Melbourne Vic. Australia

5. Department of Epidemiology and Preventative Medicine; Monash University; Melbourne Vic. Australia

6. Infectious Diseases Unit; Royal Adelaide Hospital; Adelaide SA Australia

7. Victorian Infectious Diseases Service; Royal Melbourne Hospital; Melbourne Vic. Australia

8. Department of Infectious Disease and Immunology; St Vincent's Hospital; Sydney NSW Australia

Funder

National Institute on Drug Abuse

Janssen-Cilag Pty Ltd

Gilead Sciences

National Health and Medical Research Council

AbbVie

Bristol-Myers Squibb

Merck

Boehringer-Ingelheim Pty Ltd

ViiV Healthcare

Roche

Vertex Pharmaceuticals

Department of Health, Australian Government

Victorian Operational Infrastructure Support Program

National Institutes of Health

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

Reference61 articles.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献